SSA
NVO

SSA Swiss Advisors’s Novo Nordisk NVO Stock Holding History

SSA Swiss Advisors’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.81M Hold
58,536
– – 1.05% 38
2026
Q1 		$2.14M Hold
58,536
– – 0.99% 45
2025
Q4 		$2.98M Sell
58,536
-1,365
-2% -$69.8K 1.39% 36
2025
Q3 		$3.33M Hold
59,901
– – 1.55% 27
2025
Q2 		$4.17M Buy
59,901
+12,845
+27% +$874K 2.01% 15
2025
Q1 		$3.27M Buy
+47,056
New +$3.89M 1.68% 21

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

SSA Swiss Advisors's NVO Position: Q2 2026 in Review

SSA Swiss Advisors held its Novo Nordisk (NVO) position steady in Q2 2026 at 58,536 shares worth $2.81M. The position accounts for 1.05% of the portfolio, ranked #38.

SSA Swiss Advisors first reported a position in NVO in Q1 2025 and has held it in 6 quarters since. The position peaked at $4.17M in Q2 2025. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • SSA Swiss Advisors held 58,536 shares of Novo Nordisk worth $2.81M as of Q2 2026.
  • SSA Swiss Advisors left its Novo Nordisk share count unchanged in Q2 2026.
  • Novo Nordisk made up 1.05% of SSA Swiss Advisors's portfolio in Q2 2026, its #38 holding.
  • SSA Swiss Advisors first reported a position in Novo Nordisk in Q1 2025 and has held it in 6 quarters since.
  • SSA Swiss Advisors's Novo Nordisk position peaked at $4.17M in Q2 2025.
  • 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on SSA Swiss Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.